Detalhe da pesquisa
1.
Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic study.
J Clin Psychopharmacol
; 34(2): 212-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24577256
2.
Risk of neutropenia among clozapine users and non-users: results from 5,847 patients.
Braz J Psychiatry
; 44(1): 21-25, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34730717
3.
Proinflammatory and anti-inflammatory biomarkers in schizophrenia and influence of simvastatin on the interleukin-6.
Int Clin Psychopharmacol
; 34(2): 84-88, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30461427
4.
Risk of neutropenia among clozapine users and non-users: results from 5,847 patients
Braz. J. Psychiatry (São Paulo, 1999, Impr.)
; 44(1): 21-25, Jan.-Feb. 2022. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1360182
5.
Resveratrol Supplementation Did Not Improve Cognition in Patients with Schizophrenia: Results from a Randomized Clinical Trial.
Front Psychiatry
; 7: 159, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27695423
6.
Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors.
Nutrients
; 8(2): 73, 2016 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26840331
7.
Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder.
J Psychiatr Res
; 47(10): 1546-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23702250
8.
BDNF: a biomarker for social vulnerability in individuals diagnosed with gender dysphoria.
J Psychiatr Res
; 50: 16-7, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24332481
9.
Differences in eotaxin serum levels patients with recent onset and in chronic stable schizophrenia: a clue for understanding accelerating aging profile.
Schizophr Res
; 152(2-3): 528-9, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24439271